Conditional approval for Spikevax vaccine for 12-year-olds and above
The Spikevax brand COVID-19 vaccine produced by Rovi Pharma Industrial Services in Spain has been given conditional approval for use in Malaysia by 12-year-olds and above.
Thu Aug 04 2022
Kerajaan lulus vaksin COVID-19 Spikevax untuk individu 12 tahun ke atas
Vaksin COVID-19 Spikevax keluaran Rovi Pharma Industrial Services di Sepanyol diberikan kelulusan bersyarat untuk kegunaan individu berusia 12 tahun ke atas, kata Ketua Pengarah Kesihatan.
Thu Aug 04 2022
Conditional approval for Moderna vaccine from plant in Spain
The DCA today gave conditional registration approval to Spikevax 0.20 mg/ml Dispersion for Injection COVID-19 mRNA Vaccine (nucleoside modified), also known as COVID-19 Moderna vaccine.
Thu Aug 05 2021